Proto Labs, Inc. (PRLB) Stock Price & Analysis
Proto Labs, Inc. (PRLB) closed at USD 87.41 on Thursday, October 15, 2026, down 1.75% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 88.97; the Oct 15, 2026 session ranged USD 84–88.23 on volume of 281,149 shares. Market capitalization is $2.09B, with a 52-week range of USD 45.1–99.96 (NYQ). Source: Nexqual, retrieved October 16, 2026 at 05:22 UTC.
Also available as compact Markdown for AI agents: nexqual.com/PRLB.md
Key facts (PRLB)
- Last four reported quarters (through Jun 30, 2026): revenue $561M, net income $30.5M (5.4% margin), free cash flow $56.7M (SEC filings).
- Valuation: P/E 68.6x (avg 58.8x at the last 3 fiscal year-ends).
- 1 of 80 tracked superinvestors hold PRLB (13F, Q2 2026): 0 new, 0 added, 1 reduced, 0 unchanged.
- Analysts: Buy (mean 2.00 on a 1–5 scale) (5 analysts), mean target USD 95.5 (range 87–110).
- Total return with dividends: 1Y +60.3% vs S&P 500 +18.1%; 5Y +23.4% vs S&P 500 +85.1%.
- Next earnings: 2026-10-29, EPS estimate USD 0.6, revenue estimate $149M.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (PRLB)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $488M | $488M | $504M | $501M | $533M | $561M |
| Gross profit | $223M | $215M | $222M | $223M | $237M | — |
| Operating income | $40.3M | -$98.0M | $28.2M | $19.9M | $25.1M | $36.8M |
| Net income | $33.4M | -$103M | $17.2M | $16.6M | $21.2M | $30.5M |
| EPS (diluted) | $1.21 | -$3.77 | $0.66 | $0.66 | $0.88 | — |
| Free cash flow | $21.0M | $40.4M | $45.2M | $68.7M | $59.7M | $56.7M |
| Gross margin | 45.6% | 44.1% | 44.1% | 44.6% | 44.5% | — |
| Operating margin | 8.3% | -20.1% | 5.6% | 4.0% | 4.7% | 6.6% |
| Net margin | 6.8% | -21.2% | 3.4% | 3.3% | 4.0% | 5.4% |
| Revenue growth | +12.4% | +0.1% | +3.2% | -0.6% | +6.4% | — |
| Cash + short-term investments | $77.5M | $80.1M | $103M | $103M | $128M | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (PRLB)
P/E 68.6x · P/S 3.7x · P/FCF 36.9x · P/B 3.0x · FCF yield 2.71% · Earnings yield 1.46% · Buyback yield (TTM) 1.15%
P/E at fiscal year-ends: Dec 2025 57.7x, Dec 2024 59.4x, Dec 2023 59.3x.
Superinvestors (SEC 13F-HR, Q2 2026) (PRLB)
1 of 80 tracked investors hold PRLB. Change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Polen Capital | Polen Capital Management | 0.02% | $2.9M | Reduced -6.9% |
Analysts (PRLB)
Consensus Buy (mean 2.00 on a 1–5 scale), 5 analysts; mean target USD 95.5 (low 87, high 110).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-08-03 | Needham | Upgrade | Hold → Buy | $87 |
| 2026-07-06 | Benchmark | Target raised | Buy | $70 → $91 |
Total return (dividends reinvested) (PRLB)
| 1Y (from 2025-10-16) | 5Y (from 2021-10-11) | |
|---|---|---|
| Total return | +60.3% | +23.4% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | +60.6% | +4.3% |
| Volatility (annualized) | 46.0% | 48.2% |
| Max drawdown | -19.5% (Feb 2026→Mar 2026) | -67.4% (Oct 2021→Oct 2023) |
Key Statistics (as of October 16, 2026 at 05:22 UTC)
| Price | USD 87.41 |
|---|---|
| Change | ▼ 1.75% (down) |
| Previous Close | USD 88.97 |
| Open | USD 87.8 |
| Day Range | USD 84 – 88.23 |
| 52-Week Range | USD 45.1 – 99.96 |
| Volume | 281,149 shares |
| Market Cap | $2.09B |
| Exchange | NYQ |
Technical Analysis (PRLB)
Nexqual's technical model rates PRLB "NEUTRAL" based on 3 bullish and 2 bearish signals across 127 daily candles, as of October 16, 2026 at 05:22 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 44.53 (neutral) |
| vs SMA50 | Above (USD 86.96) |
| MACD | 1.4 (positive) |
Analyst Ratings (PRLB)
Wall Street analysts rate PRLB "Buy" based on 5 analysts, with a mean price target of USD 95.5 (range USD 87–110), per Nexqual as of October 16, 2026 at 05:22 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 5 |
| Mean Target | USD 95.5 |
| High Target | USD 110 |
| Low Target | USD 87 |
| Buy / Hold / Sell | 4 / 1 / 0 |
Earnings (PRLB)
| Next Earnings Date | 2026-10-29 |
|---|---|
| EPS Estimate | USD 0.6 |
| Revenue Estimate | $149.04M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 0.6 vs est 0.54 ▲ beat |
| 2026-03-31 | USD 0.54 vs est 0.39 ▲ beat |
| 2025-12-31 | USD 0.44 vs est 0.34 ▲ beat |
| 2025-09-30 | USD 0.47 vs est 0.39 ▲ beat |
Source: Nexqual, October 16, 2026 at 05:22 UTC.
Financials & Fundamentals (PRLB)
| Total Revenue | $560.54M |
|---|---|
| Revenue Growth (latest quarter, YoY) | +10.60% |
| Gross Margin | +45.42% |
| Operating Margin | +8.85% |
| Profit Margin | +5.44% |
| ROE | +4.49% |
| Debt / Equity | 0 |
| Current Ratio | 3.64 |
| Total Cash | $142.78M |
| Total Debt | $2.24M |
| Free Cash Flow (fiscal year ended Dec 2025, SEC 10-K) | $59.66M (11.2% of revenue) |
Source: Nexqual, October 16, 2026 at 05:22 UTC.
Financial Health Score (PRLB)
Nexqual rates Proto Labs, Inc.'s overall financial health "Solid" across five dimensions, as of October 16, 2026 at 05:22 UTC.
| Growth | Solid — Revenue +6% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 45%, operating 9% |
| Balance Sheet | Strong — $143M cash vs $2M debt, net cash position |
| Cash Flow | Solid — FCF $60M (FY ended Dec 2025, 10-K), 11% margin |
| Efficiency | Weak — ROE 4%, ROA 3.3% |
Ownership (PRLB)
| Insider Ownership | +1.27% |
|---|---|
| Institutional Ownership | +95.99% |
| Shares Outstanding | 23.92M |
| Float | 23.65M |
| Short % of Float | +4.25% |
Source: Nexqual, October 16, 2026 at 05:22 UTC.
Leadership (PRLB)
Proto Labs, Inc. is led by Suresh Krishna (age 56), President, CEO & Director, per Nexqual as of October 16, 2026 at 05:22 UTC.
| President, CEO & Director | Suresh Krishna (age 56) |
|---|---|
| CFO and Principal Financial & Accounting Officer | Daniel Schumacher (age 50) |
| Chief Technology & AI Officer | Marc A. Kermisch (age 51) |
| Chief Marketing Officer | Brian F. Peters |
Major Backers & Investors (PRLB)
Notable institutional backers of Proto Labs, Inc. include Disciplined Growth Investors, Inc., American Capital Management, Inc., Renaissance Technologies, according to Nexqual as of October 16, 2026 at 05:22 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Disciplined Growth Investors, Inc. | 9.95% |
| American Capital Management, Inc. | 2.59% |
| Renaissance Technologies | 1.96% |
| Prudential Financial, Inc. | 1.91% |
| Fidelity | 1.1% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 26.82% |
| Vanguard Group | 19.13% |
| State Street | 5.69% |
| Dimensional Fund Advisors | 4.82% |
| Geode Capital | 2.57% |
Source: Nexqual, October 16, 2026 at 05:22 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| WOR | Worthington Enterprises, Inc. | USD 63.84 | ▲ 0.14% |
| RYZ | Ryerson Holding Corporation | USD 26.72 | ▼ 0.52% |
| GPGI | GPGI, Inc. | USD 12.69 | ▼ 0.24% |
| ESAB | ESAB Corporation | USD 65.63 | ▼ 1.84% |
| IIIN | Insteel Industries, Inc. | USD 29.67 | ▼ 2.27% |
| MEC | Mayville Engineering Company, I | USD 14.21 | ▼ 3.73% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 16, 2026 at 05:22 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt